Document details
 Download
  View PDF
 Add to my

Post-marketing reporting of adverse drug reactions to human medicines in South Africa

Medicines Control Council (MCC), Department of Health Republic of South Africa (2017) C2
This document has been prepared to serve as a guideline to those reporting adverse drug reactions.
Source:
https://www.mccza.com/documents/d449f6f32.33_ADR_reporting_post-marketing_Jun17_v5_showing_changes.pdf
Topics:
drug reaction adverse drug reactions adverse reactions monitoring of adverse effects South Africa country guidelines National Guidelines post-marketing reporting
Countries:
South Africa